Retinitis Pigmentosa News and Research

RSS
Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Photoreceptor cells capture and process light helping us to see. As these cells breakdown and die, patients experience progressive vision loss. The most common feature of all forms of RP is a gradual breakdown of rods (retinal cells that detect dim light) and cones (retinal cells that detect light and color). Most forms of RP first cause the breakdown of rod cells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness. Night blindness is somewhat like the experience normally sighted individuals encounter when entering a dark movie theatre on a bright, sunny day. However, patients with RP cannot adjust well to dark and dimly lit environments.
Research team detects novel mechanism of inheritance

Research team detects novel mechanism of inheritance

Complement system shown to remove dead cells in retinitis pigmentosa, contradicting previous research

Complement system shown to remove dead cells in retinitis pigmentosa, contradicting previous research

Developing imaging techniques for early detection of eye and brain diseases

Developing imaging techniques for early detection of eye and brain diseases

Study finds no damaging role for microglia during retinal prion disease in mice

Study finds no damaging role for microglia during retinal prion disease in mice

Promising gene therapy could restore vision in humans

Promising gene therapy could restore vision in humans

New therapy could help prolong useful vision and delay total blindness

New therapy could help prolong useful vision and delay total blindness

Gene behind mitochondrial disease has more varied effects than previously thought

Gene behind mitochondrial disease has more varied effects than previously thought

CIRM announces funding for UCI researchers to develop new treatment for Huntington’s disease

CIRM announces funding for UCI researchers to develop new treatment for Huntington’s disease

NIH grants awarded to Nanoscope to recruit talent and develop optogenetic delivery platforms

NIH grants awarded to Nanoscope to recruit talent and develop optogenetic delivery platforms

Early studies and recent clinical trials on nerve growth factor

Early studies and recent clinical trials on nerve growth factor

Researchers successfully restore sense of vision in blind people using BVT's bionic eye

Researchers successfully restore sense of vision in blind people using BVT's bionic eye

NEI investigators combine two imaging modalities to view the retina in unprecedented detail

NEI investigators combine two imaging modalities to view the retina in unprecedented detail

Researchers to develop new stem cell-based strategies for treating vision disorders

Researchers to develop new stem cell-based strategies for treating vision disorders

Excessive use of erectile-dysfunction medication could lead to long-term vision problems

Excessive use of erectile-dysfunction medication could lead to long-term vision problems

First U.S. patient treated with innovative gene therapy at Bascom Palmer Eye Institute

First U.S. patient treated with innovative gene therapy at Bascom Palmer Eye Institute

Scientists publish study results of AAV therapy product for treatment of RHO-adRP

Scientists publish study results of AAV therapy product for treatment of RHO-adRP

Scientists report novel gene therapy that halts vision loss in canine model of blinding disease

Scientists report novel gene therapy that halts vision loss in canine model of blinding disease

Researchers create the world’s first artificial retina

Researchers create the world’s first artificial retina

Mount Sinai study could transform treatment for patients with retinal degenerative diseases

Mount Sinai study could transform treatment for patients with retinal degenerative diseases

Scientists reverse congenital blindness in mouse model

Scientists reverse congenital blindness in mouse model